IMspire170: New combination treatment for advanced melanoma
IMspire170: New combination treatment for advanced melanoma
CheckMate 067: Nivolumab plus ipilimumab combination therapy in advanced melanoma
ARIEL3: Rucaparib maintenance treatment for recurrent ovarian carcinoma
PROMISE-meso trial results: Pembrolizumab vs chemotherapy for advanced pleural mesothelioma
Checkmate 227: Final analysis for the non small cell lung cancer trial
PARP inhibitors for metastatic breast cancer
KATHERINE trial updates for HER2-positive breast cancer
Lutetium-177 PSMA scanning for prostate cancer
Highlights from ESMO 2019
AMG 510: A novel molecule targeting KRAS G12C mutant solid tumours
MEDIOLA: Olaparib and durvalumab for germline BRCA-mutated metastatic breast cancer
Blood first assay screening in patients with ALK positive NSCLC